📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
35
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split
65%
• 50-day avg $0.27 below $1 exchange minimum
• 11 months cash with weak price
💰 Capital Raise
15%
• Under 12 months cash (11mo)
💹 Market Data
Market Cap$17.83M
Shares Outstanding89.17M
Float52.01M
Cash$4.12M
Debt$10.81M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest5.5K
Days to Cover1.0
% of Float0.0%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Feb 28, 2026
xbrl
XBRL CONVERTIBLE
Nov 30, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for KARX
📊 KARX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 KARX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.